Table 1.

Characteristics of the study participants

Characteristic	HC	AVa,b	VIb
No. of subjects	12	13	16
Gender
Male	8	9	14
Female	4	4	2
Ethnicity
Caucasian	5	0	2
African American	3	13	14
Asian	2	0	0
Mixed	2	0	0
Median age, yr (range)	32 (20–56)	46 (33–65)	37 (22–50)
Median CD4 count,c cells/μl (range)	632 (375–1,094)	329 (31–988)	104 (4–465)
Median viral load, copies/ml (range)	NAd	<100	129,092 (4,189–676,811)

^aThe duration of the cART regimen was greater than 6 months for all aviremic subjects.

^bAll HIV-1-infected subjects (aviremic and viremic) were classified as CDC stage C3.

^cP < 0.05 for HC versus VI and AV versus VI.

^dNA, not applicable.